Fellowship · Salt Lake City, UT
Sponsored by University of Utah Health
Trial of Cinpanemab in Early Parkinson's Disease.
The New England journal of medicine · 2022 · 283 citations · Kyle Fraser
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society · 2023 · 102 citations · Kyle Fraser
Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer.
Nature · 2025 · 30 citations · Benjamin Witt
Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial.
Neurology · 2024 · 35 citations · Kyle Fraser
LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society · 2026 · 6 citations · Kyle Fraser
Prospective Study of Gray Matter Atrophy Following Pediatric Mild Traumatic Brain Injury.
Neurology · 2023 · 22 citations · Phillip Stephenson
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis.
Nature communications · 2023 · 38 citations · Daniel Albertson
Neurologic Features Associated With SARS-CoV-2 Infection in Children: A Case Series Report.
Journal of child neurology · 2021 · 40 citations · Gonzalo Barraza